WAND (Milestone Scientific) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : WAND (Milestone Scientific)

MS 162.35

-0.7%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jeff Tribble who wrote (429)	4/19/1998 4:37:00 PM
From: SeveCords	of 717

Your comments in this instance are a bit silly. First of all Bob has admitted that he is long the stock, but more importantly the vast majority of the the dentists who have already purchased the device (I believe that number approaches 12,000) now seem to confirm that more than a few people believe in its merit. You make it sound like it is totally worthless just because you haven't found anyone who likes it yet. I would remind you that this is the most successful product roll out in the history of the dental business. If you had taken the time to visit any of the dental shows you would have noticed immediately there is an immense amount of interest in the product. The crowds around the booths have been 3 and 4 people deep. If the sales were going so poorly as the shorts on this board would have you believe, why would Schein and Patterson be at the Anaheim dental show right now selling the product. Believe me, they would have dropped it by now. As far as your comment that no dentists on this board are expounding its virtue, you are mistaken. Go back and check SKIDENT123's comments. Also review SHAWFISH's comments. He's doing clinical studies in podiatry and is experiencing tremendous success. By the way I am long the stock too, and I can accept that sales are not likely to continue at this pace at least until the CRA reviews the product this summer. After all, we are through the early adopter stage and the next 10% will probably be harder to get than the first 10%. This may be the natural course of action and shouldn't immediately be interpreted as a total lack of interest in the product. Some people take longer to adapt to new ways of doing things. Think back to computers, or ATM machines just a few short years ago. Now we can't live without them. There weren't many people who thought that this company would have achieved this kind of market penetration by now. As far as your insinuation that by looking to develop international sales or other medical uses at this point, the company must be failing in some way. This too makes no sense. Why should the company wait to pursue international sales or additional medical disciplines? If this were your company, would you? As a shareholder I applaud this as this will add value to the franchise. Hope this helps you clarify your thinking. Steve

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next